Cargando…

Influence of Dopaminergic Medication on Conditioned Pain Modulation in Parkinson's Disease Patients

BACKGROUND: Pain is highly prevalent in patients with Parkinson’s disease (PD), but little is known about the underlying pathophysiological mechanisms. The susceptibility to pain is known to depend on ascending and descending pathways. Because parts of the descending pain inhibitory system involve d...

Descripción completa

Detalles Bibliográficos
Autores principales:	Grashorn, Wiebke, Schunke, Odette, Buhmann, Carsten, Forkmann, Katarina, Diedrich, Sabrina, Wesemann, Katharina, Bingel, Ulrike
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2015
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4536013/ https://www.ncbi.nlm.nih.gov/pubmed/26270817 http://dx.doi.org/10.1371/journal.pone.0135287

Ejemplares similares

Conditioned pain modulation in drug-naïve patients with de novo Parkinson’s disease
por: Grashorn, Wiebke, et al.
Publicado: (2019)

Age-Dependent Decline of Endogenous Pain Control: Exploring the Effect of Expectation and Depression
por: Grashorn, Wiebke, et al.
Publicado: (2013)

Enhanced pain-related conditioning for face compared to hand pain
por: Schmidt, Katharina, et al.
Publicado: (2020)

Phasic and Tonic Pain Differentially Impact the Interruptive Function of Pain
por: Sinke, Christopher, et al.
Publicado: (2015)

Does pain modality play a role in the interruptive function of acute visceral compared with somatic pain?
por: Kleine-Borgmann, Julian, et al.
Publicado: (2022)

Impaired pain-related threat and safety learning in patients with chronic back pain
por: Schlitt, Frederik, et al.
Publicado: (2022)

Effects of open-label placebos on test performance and psychological well-being in healthy medical students: a randomized controlled trial
por: Kleine-Borgmann, Julian, et al.
Publicado: (2021)

Open-label placebo treatment does not enhance cognitive abilities in healthy volunteers
por: Hartmann, Helena, et al.
Publicado: (2023)

The Effect of Treatment History on Therapeutic Outcome: Psychological and Neurobiological Underpinnings
por: Kessner, Simon, et al.
Publicado: (2014)

Management of Pain in Parkinson’s Disease
por: Buhmann, Carsten, et al.
Publicado: (2020)

Acquisition learning is stronger for aversive than appetitive events
por: van der Schaaf, Marieke E., et al.
Publicado: (2022)

Dopaminergic modulation of emotional conflict in Parkinson's disease
por: Fleury, Vanessa, et al.
Publicado: (2014)

Dopaminergic Modulation of Prospective Memory in Parkinson’s Disease
por: Costa, Alberto, et al.
Publicado: (2008)

Dopaminergic modulation of the praxis network in Parkinson's disease
por: Matt, Eva, et al.
Publicado: (2019)

Dopaminergic modulation of motor network dynamics in Parkinson’s disease
por: Michely, Jochen, et al.
Publicado: (2015)

Role of Descending Dopaminergic Pathways in Pain Modulation
por: Li, Changsheng, et al.
Publicado: (2019)

Motivational modulation of bradykinesia in Parkinson’s disease off and on dopaminergic medication
por: Kojovic, Maja, et al.
Publicado: (2014)

Dopaminergic Modulation of Medial Prefrontal Cortex Deactivation in Parkinson Depression
por: Andersen, Anders H., et al.
Publicado: (2015)

Dopaminergic Modulation of Biological Motion Perception in patients with Parkinson’s disease
por: Liu, Tingting, et al.
Publicado: (2017)

Theory of mind deficits in Parkinson’s disease are not modulated by dopaminergic medication
por: Usnich, Tatiana, et al.
Publicado: (2023)

Dopaminergic Modulation of Sensory Attenuation in Parkinson's Disease: Is There an Underlying Modulation of Beta Power?
por: Macerollo, Antonella, et al.
Publicado: (2019)

Dopaminergic Pathway Genes Influence Adverse Events Related to Dopaminergic Treatment in Parkinson's Disease
por: Redenšek, Sara, et al.
Publicado: (2019)

Decoding the perception of pain from fMRI using multivariate pattern analysis
por: Brodersen, Kay H., et al.
Publicado: (2012)

Evidence for dopaminergic involvement in endogenous modulation of pain relief
por: Desch, Simon, et al.
Publicado: (2023)

Parkinson's disease and dopaminergic neurons
Publicado: (2012)

Differential dopaminergic modulation of spontaneous cortico–subthalamic activity in Parkinson’s disease
por: Sharma, Abhinav, et al.
Publicado: (2021)

Influence of Depressive Symptoms on Dopaminergic Treatment of Parkinson’s Disease
por: Hanganu, Alexandru, et al.
Publicado: (2014)

Blood neurofilament light chain in Parkinson’s disease
por: Buhmann, Carsten, et al.
Publicado: (2023)

Gait Training in Virtual Reality: Short-Term Effects of Different Virtual Manipulation Techniques in Parkinson’s Disease
por: Janeh, Omar, et al.
Publicado: (2019)

No long-term effects after a 3-week open-label placebo treatment for chronic low back pain: a 3-year follow-up of a randomized controlled trial
por: Kleine-Borgmann, Julian, et al.
Publicado: (2023)

Dopaminergic modulation of performance monitoring in Parkinson’s disease: An event-related potential study
por: Seer, Caroline, et al.
Publicado: (2017)

The hypothalamic-spinal dopaminergic system: a target for pain modulation
por: Puopolo, Michelino
Publicado: (2019)

Modulation of miR-181 influences dopaminergic neuronal degeneration in a mouse model of Parkinson’s disease
por: Stein, Colleen S., et al.
Publicado: (2022)

Parkinson’s Disease, the Dopaminergic Neuron and Gammahydroxybutyrate
por: Mamelak, Mortimer
Publicado: (2018)

Device-Aided Therapies in Parkinson’s Disease—Results from the German Care4PD Study
por: Fründt, Odette, et al.
Publicado: (2023)

Hypomania and saccadic changes in Parkinson’s disease: influence of D2 and D3 dopaminergic signalling
por: Pelzer, Esther A., et al.
Publicado: (2020)

Dopaminergic modulation of positive expectations for goal-directed action: evidence from Parkinson’s disease
por: Wolpe, Noham, et al.
Publicado: (2015)

The Distinct Functions of Dopaminergic Receptors on Pain Modulation: A Narrative Review
por: Wang, Xia-qing, et al.
Publicado: (2021)

Vulnerability of Mesostriatal Dopaminergic Neurons in Parkinson's Disease
por: González-Hernández, Tomás, et al.
Publicado: (2010)

Dopaminergic Dysregulation, Artistic Expressiveness, and Parkinson's Disease
por: López-Pousa, S., et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_4m2c7p2gddo63hs2tj07983lu1